A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the “on‐demand” scheme of administration at French autologous hematopoietic stem cell transplant programs

Publisher: John Wiley & Sons Inc

E-ISSN: 1537-2995|55|9|2149-2157

ISSN: 0041-1132

Source: TRANSFUSION, Vol.55, Iss.9, 2015-09, pp. : 2149-2157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content